Imagine simple test that, with a few drops of urine, could detect breast cancer. Could it be possible? Yes, at Harvard, it is being developed. Researchers and scientists from Harvard’s Children's Hospital in Boston are working to develop a simple breast cancer "dipstick test" to detect breast cancer at very early stages. Marsha Moses, director of the Vascular Biology Program at Children's Hospital, has been working on the exciting research area of bio-markers that use biological compounds that could signal or warn patients about the potential risk of developing cancer breast cancer.The MMP-9 and ADAM-12 biomarkers data has been licensed to a biotech company that will work on a simple breast cancer dipstick in which a few drops could be rapidly used to asses the risk of a woman to develop breast cancer. In this way certain drugs, that inhibits angiogenesis, could be administered without even knowing where the tumor is. The breast cancer dipstick test is not available commercially yet but we will probably see it soon in the market.
